chlorpromazine has been researched along with primaquine in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (48.39) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (16.13) | 29.6817 |
| 2010's | 11 (35.48) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Fitos, I; Mády, G; Visy, J; Zsila, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahman, M; Holmén, AG; Wan, H | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Johnson, M; Junga, I; Krueger, J; Schrier, SL | 2 |
| Rinehart, J; Zarkowsky, H | 1 |
| Bensch, KG; Hardy, B; Schrier, SL | 1 |
| Garfinkel, E; Hirschman, SZ | 1 |
| Greenwalt, TJ; Lau, FO; Swierk, EM; Williams, RE | 1 |
| Allison, RG; Hahn, FE | 1 |
| Junga, I; Ma, L; Schrier, SL | 1 |
| Akintonwa, DA | 1 |
| Junga, IG; Matovcik, LM; Schrier, SL | 1 |
| Ben-Bassat, I; Bensch, KG; Schrier, SL | 1 |
| Curry, MC; Dustin, R; Kahn, G | 1 |
| Fujii, T; Nakanishi, K; Sato, T | 1 |
| Goldschmidt, L | 1 |
| Chiu, DT; Lubin, B; Schrier, SL; Sizer, K; Yee, M | 1 |
| Bhoopathy, S; Karnes, HT; Unger, SE; Xin, B | 1 |
| Ahting, U; Bader, B; Danek, A; Gregory, A; Hamminger, P; Hartig, M; Hayflick, S; Hermann, A; Jank, H; Prohaska, R; Prokisch, H; Salzer, U; Sammler, EM; Siegl, C; Yapici, Z | 1 |
| Chen, S; Guo, L; Ning, B; Tolleson, WH; Xuan, J | 1 |
1 review(s) available for chlorpromazine and primaquine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for chlorpromazine and primaquine
| Article | Year |
|---|---|
Studies on the effect of clinical dosages of chlorpromazine and other neurotropics on primaquine-sensitive Negro mental patients.
Topics: Adult; Anemia, Hemolytic; Black or African American; Chlorpromazine; Clinical Trials as Topic; Dementia; Female; Glucosephosphate Dehydrogenase Deficiency; Glutathione; Hematocrit; Hemoglobinometry; Humans; Male; Neurotic Disorders; Primaquine; Psychopharmacology; Psychoses, Alcoholic; Schizophrenia | 1966 |
29 other study(ies) available for chlorpromazine and primaquine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Selective plasma protein binding of antimalarial drugs to alpha1-acid glycoprotein.
Topics: Antimalarials; Binding Sites; Chromatography, Affinity; Circular Dichroism; Humans; Molecular Structure; Orosomucoid; Protein Binding; Serum Albumin; Spectrophotometry; Stereoisomerism; Structure-Activity Relationship | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Requirements of drug-induced endocytosis by intact human erythrocytes.
Topics: Calcium; Chlorpromazine; Cyclic AMP; Cyclic GMP; Cytochalasin B; Endocytosis; Erythrocytes; Humans; Primaquine; Vinblastine | 1978 |
Endocytosis in adenosine triphosphate-depleted erythrocytes.
Topics: Adenosine Triphosphate; Chlorpromazine; Endocytosis; Erythrocytes; Humans; Primaquine | 1979 |
Endocytosis in erythrocytes and their ghosts.
Topics: Adenosine Triphosphate; Calcium; Chlorpromazine; Cytochalasins; Diamide; Endocytosis; Erythrocyte Membrane; Erythrocytes; Humans; In Vitro Techniques; Primaquine; Spectrin; Vinblastine | 1979 |
Inhibition of hepatitis B DNA polymerase by intercalating agents.
Topics: Chloroquine; Chlorpromazine; Drug Synergism; Ethidium; Hepatitis B; Hepatitis B virus; Humans; Indicators and Reagents; Methylene Blue; Nucleic Acid Synthesis Inhibitors; Primaquine; Quinacrine | 1978 |
Studies of erythrocyte membrane loss produced by amphipathic drugs and in vitro storage.
Topics: Adenosine Triphosphate; Blood Preservation; Chlorpromazine; Endocytosis; Erythrocyte Aging; Erythrocyte Membrane; Erythrocytes; Humans; In Vitro Techniques; Microscopy, Electron, Scanning; Primaquine; Propranolol; Tetracaine; Tolonium Chloride | 1978 |
Changes in superhelical density of closed circular deoxyribonucleic acid by intercalation of anti-R-plasmid drugs and primaquine.
Topics: Acridines; Chemical Phenomena; Chemistry; Chloroquine; Chlorpromazine; DNA, Circular; Ethidium; Extrachromosomal Inheritance; Methylene Blue; Plasmids; Primaquine; Pseudomonas; Quinine | 1977 |
Studies on the effect of vanadate on endocytosis and shape changes in human red blood cells and ghosts.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Chlorpromazine; Endocytosis; Erythrocyte Membrane; Erythrocytes; Humans; Primaquine; Vanadium; Vinblastine | 1986 |
The derivation of nitrosamines from some therapeutic amines in the human environment.
Topics: Amines; Carcinogens; Chemical Phenomena; Chemistry; Chloroquine; Chlorpromazine; Humans; Methadone; Mixed Function Oxygenases; Nitrosamines; Pharmaceutical Preparations; Phenacetin; Primaquine | 1985 |
Drug-induced endocytosis of neonatal erythrocytes.
Topics: Adenosine Triphosphate; Adult; Age Factors; Aspartate Aminotransferases; Chlorpromazine; Densitometry; Endocytosis; Erythrocyte Aging; Erythrocyte Indices; Erythrocyte Membrane; Erythrocytes; Glucosephosphate Dehydrogenase; Humans; Infant, Newborn; Primaquine; Vinblastine | 1985 |
Drug-induced erythrocyte membrane internalization.
Topics: Adenosine Triphosphate; Calcium; Chlorpromazine; Cytoplasm; Erythrocyte Aging; Erythrocytes; Ethylmaleimide; Fluorides; Humans; Hydrocortisone; Hydrogen-Ion Concentration; In Vitro Techniques; Magnesium; Membranes; Microscopy, Electron; Microscopy, Phase-Contrast; Primaquine; Sulfonic Acids; Vinblastine | 1972 |
New approaches to investigating UVL photo protective substances in vitro.
Topics: 1-Propanol; Aminobenzoates; Aniline Compounds; beta-Aminoethyl Isothiourea; Candida albicans; Chlorpromazine; Dithiothreitol; Erythrocytes; Gallic Acid; Hemolysis; Mercaptoethylamines; Oxygen; Partial Pressure; Primaquine; Radiation Effects; Radiation-Protective Agents; Sulfoxides; Thiram; Tuberculin; Ultraviolet Rays | 1973 |
In vitro shape changes of human erythrocyte membranes.
Topics: Adenosine Triphosphate; Aluminum; Cell Membrane; Chloromercuribenzoates; Chlorpromazine; Erythrocytes; Ethanol; Ethylmaleimide; Hot Temperature; Humans; Microscopy, Electron, Scanning; Nitrobenzenes; Osmolar Concentration; Osmotic Fragility; Phosphatidylcholines; Primaquine; Saponins; Sodium Chloride; Spectrophotometry; Sulfonic Acids; Surface-Active Agents | 1973 |
Alteration of membrane phospholipid bilayer organization in human erythrocytes during drug-induced endocytosis.
Topics: Chlorpromazine; Endocytosis; Erythrocyte Membrane; Erythrocytes; Humans; Lipid Bilayers; Phosphatidylcholines; Phosphatidylethanolamines; Phospholipases A; Phospholipases A2; Phospholipids; Primaquine; Sphingomyelin Phosphodiesterase; Vinblastine | 1983 |
Calcium distribution within human erythrocytes during endocytosis.
Topics: Adenosine Triphosphate; Calcium; Chlorpromazine; Endocytosis; Erythrocytes; Humans; Primaquine; Vinblastine | 1980 |
A novel incubation direct injection LC/MS/MS technique for in vitro drug metabolism screening studies involving the CYP 2D6 and the CYP 3A4 isozymes.
Topics: Algorithms; Animals; Antitussive Agents; Chlorpromazine; Chromatography, Liquid; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dextromethorphan; Enzyme Inhibitors; Half-Life; Humans; Hypnotics and Sedatives; In Vitro Techniques; Indicators and Reagents; Isoenzymes; Microsomes, Liver; Midazolam; Pharmaceutical Preparations; Primaquine; Quinidine; Rats; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization | 2005 |
Alterations of red cell membrane properties in neuroacanthocytosis.
Topics: Acanthocytes; Adolescent; Adult; Basal Ganglia; Calcium; Case-Control Studies; Cations, Divalent; Child; Chlorpromazine; Endocytosis; Erythrocyte Membrane; Female; Humans; Imipramine; Ion Transport; Lysophospholipids; Male; Middle Aged; Neuroacanthocytosis; Pantothenate Kinase-Associated Neurodegeneration; Phosphatidylserines; Primaquine | 2013 |
Development of HepG2-derived cells expressing cytochrome P450s for assessing metabolism-associated drug-induced liver toxicity.
Topics: Amiodarone; Antimalarials; Antipsychotic Agents; Cell Line; Chemical and Drug Induced Liver Injury; Chlorpromazine; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Evaluation, Preclinical; Gene Expression; Hep G2 Cells; Humans; Liver; Primaquine; Protein Isoforms; RNA, Messenger | 2016 |